What is the treatment for bronchitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Acute Bronchitis

Antibiotics should NOT be routinely prescribed for acute bronchitis, as they provide minimal benefit (reducing cough by only about half a day) while exposing patients to adverse effects and contributing to antibiotic resistance. 1, 2

Initial Assessment and Diagnosis

Before treating for acute bronchitis, rule out pneumonia by checking for:

  • Tachycardia (heart rate >100 beats/min) 2
  • Tachypnea (respiratory rate >24 breaths/min) 2
  • Fever (oral temperature >38°C) 2
  • Abnormal chest examination findings (rales, egophony, tactile fremitus) 2

No routine investigations are recommended including chest x-ray, spirometry, sputum culture, viral PCR, or inflammatory markers (CRP, procalcitonin) at initial presentation. 1

Symptomatic Treatment Approach

First-Line Therapy: Bronchodilators

Albuterol (short-acting β2-agonist) is the recommended first-line symptomatic treatment for patients with evidence of bronchial hyperresponsiveness such as wheezing or bothersome cough. 3

  • Approximately 50% fewer patients report cough after 7 days of albuterol treatment compared to placebo 1, 3
  • Treatment reduces both duration and severity of cough 1, 3
  • Do NOT routinely use β2-agonists in patients without wheezing or clinical evidence of bronchial hyperresponsiveness 2, 4

Second-Line: Antitussives

For patients with persistent bothersome cough:

  • Dextromethorphan or codeine provide modest effects on cough severity and duration 1, 2, 4
  • These agents are more effective for cough lasting >3 weeks or cough associated with underlying lung disease 1

Adjunctive Measures

Low-cost, low-risk interventions are reasonable:

  • Elimination of environmental cough triggers (dust, dander) 1, 3
  • Vaporized air treatments, particularly in low-humidity environments 1, 3

When Antibiotics Are NOT Indicated

The presence of purulent sputum or change in sputum color does NOT signify bacterial infection and is NOT an indication for antibiotics. 2

Antibiotics reduce cough duration by only approximately 0.5 days while causing side effects and promoting resistance. 5

Exception: When to Consider Antibiotics

Pertussis (Whooping Cough)

  • Prescribe a macrolide antibiotic (erythromycin) for confirmed or suspected pertussis 2
  • Isolate patients for 5 days from start of treatment 2, 4
  • Early treatment within first few weeks diminishes coughing paroxysms and prevents spread 2

Worsening Bronchitis

  • Consider antibiotics only if the condition significantly worsens, suggesting bacterial superinfection 1, 3
  • Reassess and consider targeted investigations if symptoms persist or worsen 1

Influenza-Related Bronchitis

  • Consider antiviral agents if within 48 hours (preferably <30 hours) of symptom onset during documented influenza outbreaks 1, 2

Patient Communication Strategy

Patient satisfaction depends more on physician-patient communication than whether an antibiotic is prescribed. 1, 2

Key Points to Discuss:

  • Inform patients that cough typically lasts 10-14 days after the office visit 2, 3, 4
  • Refer to the condition as a "chest cold" rather than "bronchitis" to reduce antibiotic expectations 2, 4
  • Explain the lack of benefit of antibiotics for uncomplicated acute bronchitis 1, 2
  • Discuss potential harm of unnecessary antibiotic use including side effects and contribution to resistance 2, 4

Common Pitfalls to Avoid

  • Do not prescribe antibiotics based solely on colored or purulent sputum 2, 4
  • Do not routinely use NSAIDs at anti-inflammatory doses or systemic corticosteroids for acute bronchitis 2, 4
  • Do not fail to distinguish between acute bronchitis and pneumonia before initiating treatment 4
  • Do not overlook bronchodilator therapy which has demonstrated benefit in appropriate patients 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Acute Bronchitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Acute Bronchitis Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Bronchitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Antibiotics in acute bronchitis: a meta-analysis.

The American journal of medicine, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.